Organogenesis Holdings Stock Probability of Future Stock Price Finishing Over 3.24

ORGO Stock  USD 2.49  0.02  0.80%   
Organogenesis Holdings' implied volatility is one of the determining factors in the pricing options written on Organogenesis Holdings. Implied volatility approximates the future value of Organogenesis Holdings based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Organogenesis Holdings over a specific time period. For example, 2024-05-17 CALL at $2.5 is a CALL option contract on Organogenesis Holdings' common stock with a strick price of 2.5 expiring on 2024-05-17. The contract was last traded on 2024-05-03 at 13:06:57 for $0.2 and, as of today, has 12 days remaining before the expiration. The option is currently trading at a bid price of $0.2, and an ask price of $0.4. The implied volatility as of the 5th of May is 108.16. View All Organogenesis options

Closest to current price Organogenesis long CALL Option Payoff at Expiration

Organogenesis Holdings' future price is the expected price of Organogenesis Holdings instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Organogenesis Holdings performance during a given time horizon utilizing its historical volatility. Check out Organogenesis Holdings Backtesting, Organogenesis Holdings Valuation, Organogenesis Holdings Correlation, Organogenesis Holdings Hype Analysis, Organogenesis Holdings Volatility, Organogenesis Holdings History as well as Organogenesis Holdings Performance.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
  
At this time, Organogenesis Holdings' Price To Sales Ratio is very stable compared to the past year. As of the 5th of May 2024, Price Earnings Ratio is likely to grow to 113.97, while Price Book Value Ratio is likely to drop 1.83. Please specify Organogenesis Holdings' target price for which you would like Organogenesis Holdings odds to be computed.

Organogenesis Holdings Target Price Odds to finish over 3.24

The tendency of Organogenesis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 3.24  or more in 90 days
 2.49 90 days 3.24 
about 27.25
Based on a normal probability distribution, the odds of Organogenesis Holdings to move over $ 3.24  or more in 90 days from now is about 27.25 (This Organogenesis Holdings probability density function shows the probability of Organogenesis Stock to fall within a particular range of prices over 90 days) . Probability of Organogenesis Holdings price to stay between its current price of $ 2.49  and $ 3.24  at the end of the 90-day period is about 64.18 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.71 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Organogenesis Holdings will likely underperform. Additionally Organogenesis Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Organogenesis Holdings Price Density   
       Price  

Predictive Modules for Organogenesis Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organogenesis Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Organogenesis Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.122.497.58
Details
Intrinsic
Valuation
LowRealHigh
0.122.337.42
Details
Naive
Forecast
LowNextHigh
0.052.307.39
Details
3 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Organogenesis Holdings. Your research has to be compared to or analyzed against Organogenesis Holdings' peers to derive any actionable benefits. When done correctly, Organogenesis Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Organogenesis Holdings.

Organogenesis Holdings Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Organogenesis Holdings is not an exception. The market had few large corrections towards the Organogenesis Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Organogenesis Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Organogenesis Holdings within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.49
β
Beta against NYSE Composite2.71
σ
Overall volatility
0.38
Ir
Information ratio -0.07

Organogenesis Holdings Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organogenesis Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organogenesis Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Organogenesis Holdings generated a negative expected return over the last 90 days
Organogenesis Holdings has high historical volatility and very poor performance
About 33.0% of the company outstanding shares are owned by corporate insiders
Latest headline from investing.com: Organogenesis reports positive Phase 3 trial results for knee therapy

Organogenesis Holdings Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Organogenesis Stock often depends not only on the future outlook of the current and potential Organogenesis Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organogenesis Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding132.7 M
Cash And Short Term Investments104.3 M

Organogenesis Holdings Technical Analysis

Organogenesis Holdings' future price can be derived by breaking down and analyzing its technical indicators over time. Organogenesis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Organogenesis Holdings. In general, you should focus on analyzing Organogenesis Stock price patterns and their correlations with different microeconomic environments and drivers.

Organogenesis Holdings Predictive Forecast Models

Organogenesis Holdings' time-series forecasting models is one of many Organogenesis Holdings' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Organogenesis Holdings' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Organogenesis Holdings

Checking the ongoing alerts about Organogenesis Holdings for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Organogenesis Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Organogenesis Holdings generated a negative expected return over the last 90 days
Organogenesis Holdings has high historical volatility and very poor performance
About 33.0% of the company outstanding shares are owned by corporate insiders
Latest headline from investing.com: Organogenesis reports positive Phase 3 trial results for knee therapy
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out Organogenesis Holdings Backtesting, Organogenesis Holdings Valuation, Organogenesis Holdings Correlation, Organogenesis Holdings Hype Analysis, Organogenesis Holdings Volatility, Organogenesis Holdings History as well as Organogenesis Holdings Performance.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Organogenesis Stock analysis

When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.307
Earnings Share
0.04
Revenue Per Share
3.301
Quarterly Revenue Growth
(0.14)
Return On Assets
0.0224
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.